252 related articles for article (PubMed ID: 28115352)
1. Clinical and Microbiological Characteristics of Breakthrough Candidemia in Allogeneic Hematopoietic Stem Cell Transplant Recipients in a Japanese Hospital.
Kimura M; Araoka H; Yamamoto H; Asano-Mori Y; Nakamura S; Yamagoe S; Ohno H; Miyazaki Y; Abe M; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Uchida N; Izutsu K; Wake A; Taniguchi S; Yoneyama A
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115352
[TBL] [Abstract][Full Text] [Related]
2. Antifungal susceptibility of Candida isolates at one institution.
Katsuragi S; Sata M; Kobayashi Y; Miyoshi T; Yamashita Y; Neki R; Horiuchi C; Yamanaka K; Kamiya C; Iwanaga N; Tanaka H; Ikeda T; Yoshimatsu J
Med Mycol J; 2014; 55(1):E1-7. PubMed ID: 24682093
[TBL] [Abstract][Full Text] [Related]
3. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
4. Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
Kimura M; Araoka H; Yamamoto H; Nakamura S; Nagi M; Yamagoe S; Miyazaki Y; Ogura S; Mitsuki T; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Shimazu H; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Wake A; Taniguchi S; Yoneyama A
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530846
[TBL] [Abstract][Full Text] [Related]
5. Breakthrough fungemia due to Candida fermentati with fks1p mutation under micafungin treatment in a cord blood transplant recipient.
Konuma T; Takahashi S; Kiyuna T; Miharu Y; Suzuki M; Shibata H; Kato S; Takahashi S; Tojo A
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27859978
[TBL] [Abstract][Full Text] [Related]
6. Development of echinocandin-resistant Candida albicans candidemia following brief prophylactic exposure to micafungin therapy.
Ruggero MA; Topal JE
Transpl Infect Dis; 2014 Jun; 16(3):469-72. PubMed ID: 24810789
[TBL] [Abstract][Full Text] [Related]
7. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
[TBL] [Abstract][Full Text] [Related]
9. Three cases of Candida fermentati fungemia following hematopoietic stem cell transplantation.
Morita K; Honda A; Koya J; Toyama K; Ikeda M; Misawa Y; Okugawa S; Nakamura F; Moriya K; Kurokawa M
J Infect Chemother; 2018 Jul; 24(7):576-578. PubMed ID: 29371065
[TBL] [Abstract][Full Text] [Related]
10. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
[TBL] [Abstract][Full Text] [Related]
11. Breakthrough candidemia with hematological disease: Results from a single-center retrospective study in Japan, 2009-2020.
Nishida R; Eriguchi Y; Miyake N; Nagasaki Y; Yonekawa A; Mori Y; Kato K; Akashi K; Shimono N
Med Mycol; 2023 Jun; 61(6):. PubMed ID: 37312399
[TBL] [Abstract][Full Text] [Related]
12. Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.
Lee SC; Lee CW; Shih HJ; Huang SH; Chiou MJ; See LC
J Microbiol Immunol Infect; 2014 Jun; 47(3):245-53. PubMed ID: 24246191
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility profiles and clinical efficacy of antifungals against candida bloodstream isolates from critically ill patients: Focus on intravenous itraconazole.
Giamarellos-Bourboulis EJ; Stamou A; Maraki S; Solomonidi N; Belesiotou E; Pistiki A; Antoniadou E; Vlachogianni G; Mandragos K; Tasioudis C; Katsenos C; Routsi C; Samonis G; Dimopoulos G
Int J Antimicrob Agents; 2019 Oct; 54(4):471-477. PubMed ID: 31271830
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
[TBL] [Abstract][Full Text] [Related]
15. [Candidemia in Cancer Patients: Focus Mainly on Hematological Malignancyand Hematopoietic Stem Cell Transplantation].
Okinaka K
Med Mycol J; 2016; 57(3):J117-23. PubMed ID: 27581780
[TBL] [Abstract][Full Text] [Related]
16. Innate inflammatory response and immunopharmacologic activity of micafungin, caspofungin, and voriconazole against wild-type and FKS mutant Candida glabrata isolates.
Beyda ND; Liao G; Endres BT; Lewis RE; Garey KW
Antimicrob Agents Chemother; 2015 Sep; 59(9):5405-12. PubMed ID: 26100700
[TBL] [Abstract][Full Text] [Related]
17. Factors Associated with Breakthrough Fungemia Caused by
Kimura M; Asano-Mori Y; Sakoh T; Abe M; Ueno K; Hoshino Y; Nakamura S; Umeyama T; Yamagoe S; Miyazaki Y; Baba M; Okada C; Ogura S; Mitsuki T; Yamaguchi K; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Ishiwata K; Takagi S; Yamamoto H; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
Antimicrob Agents Chemother; 2022 Mar; 66(3):e0208121. PubMed ID: 35041512
[TBL] [Abstract][Full Text] [Related]
18. Distribution and drug susceptibilities of Candida species causing candidemia from a medical center in central Taiwan.
Chang TP; Ho MW; Yang YL; Lo PC; Lin PS; Wang AH; Lo HJ
J Infect Chemother; 2013 Dec; 19(6):1065-71. PubMed ID: 23732308
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®].
Thierry G; Morio F; Le Pape P; Gay-Andrieu F; Barre O; Miegeville M
Pathol Biol (Paris); 2011 Feb; 59(1):52-6. PubMed ID: 20832195
[TBL] [Abstract][Full Text] [Related]
20. Breakthrough candidemia due to multidrug-resistant Candida glabrata during prophylaxis with a low dose of micafungin.
Bizerra FC; Jimenez-Ortigosa C; Souza AC; Breda GL; Queiroz-Telles F; Perlin DS; Colombo AL
Antimicrob Agents Chemother; 2014; 58(4):2438-40. PubMed ID: 24468776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
